» Articles » PMID: 34680536

Initial Biological Assessment of Upconversion Nanohybrids

Overview
Journal Biomedicines
Date 2021 Oct 23
PMID 34680536
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticles for medical use should be non-cytotoxic and free of bacterial contamination. Upconversion nanoparticles (UCNPs) coated with cucurbit[7]uril (CB[7]) made by combining UCNPs free of oleic acid, here termed bare UCNPs (UC), and CB[7], i.e., UC@CB[7] nanohybrids, could be used as photoactive inorganic-organic hybrid scaffolds for biological applications. UCNPs, in general, are not considered to be highly toxic materials, but the release of fluorides and lanthanides upon their dissolution may cause cytotoxicity. To identify potential adverse effects of the nanoparticles, dehydrogenase activity of endothelial cells, exposed to various concentrations of the UCNPs, was determined. Data were verified by measuring lactate dehydrogenase release as the indicator of loss of plasma membrane integrity, which indicates necrotic cell death. This assay, in combination with calcein AM/Ethidium homodimer-1 staining, identified induction of apoptosis as main mode of cell death for both particles. The data showed that the UCNPs are not cytotoxic to endothelial cells, and the samples did not contain endotoxin contamination. Higher cytotoxicity, however, was seen in HeLa and RAW 264.7 cells. This may be explained by differences in lysosome content and particle uptake rate. Internalization of UC and UC@CB[7] nanohybrids by cells was demonstrated by NIR laser scanning microscopy.

Citing Articles

Raspberry-like Nanoheterostructures Comprising Glutathione-Capped Gold Nanoclusters Grown on the Lanthanide Nanoparticle Surface.

Perez-Herraez I, Ferrera-Gonzalez J, Zaballos-Garcia E, Gonzalez-Bejar M, Perez-Prieto J Chem Mater. 2024; 36(9):4426-4436.

PMID: 38764750 PMC: 11099914. DOI: 10.1021/acs.chemmater.3c03333.


Light Control in Microbial Systems.

Elahi Y, Baker M Int J Mol Sci. 2024; 25(7).

PMID: 38612810 PMC: 11011852. DOI: 10.3390/ijms25074001.


Bioimaging with Upconversion Nanoparticles.

Mettenbrink E, Yang W, Wilhelm S Adv Photonics Res. 2023; 3(12).

PMID: 36686152 PMC: 9858112. DOI: 10.1002/adpr.202200098.


Upconversion Nanomaterials in Bioimaging and Biosensor Applications and Their Biological Response.

Gerelkhuu Z, Lee Y, Yoon T Nanomaterials (Basel). 2022; 12(19).

PMID: 36234598 PMC: 9565472. DOI: 10.3390/nano12193470.


Optical Nanoparticles for Biomedicine.

Sole J Biomedicines. 2022; 10(8).

PMID: 36009439 PMC: 9405649. DOI: 10.3390/biomedicines10081892.

References
1.
Kembuan C, Oliveira H, Graf C . Effect of different silica coatings on the toxicity of upconversion nanoparticles on RAW 264.7 macrophage cells. Beilstein J Nanotechnol. 2021; 12:35-48. PMC: 7801781. DOI: 10.3762/bjnano.12.3. View

2.
Ding Y, Zhu H, Zhang X, Zhu J, Burda C . Rhodamine B derivative-functionalized upconversion nanoparticles for FRET-based Fe(3+)-sensing. Chem Commun (Camb). 2013; 49(71):7797-9. DOI: 10.1039/c3cc43926g. View

3.
Yu J, Yin W, Peng T, Chang Y, Zu Y, Li J . Biodistribution, excretion, and toxicity of polyethyleneimine modified NaYF:Yb,Er upconversion nanoparticles in mice via different administration routes. Nanoscale. 2017; 9(13):4497-4507. DOI: 10.1039/c7nr00078b. View

4.
Frohlich E, Meindl C, Wagner K, Leitinger G, Roblegg E . Use of whole genome expression analysis in the toxicity screening of nanoparticles. Toxicol Appl Pharmacol. 2014; 280(2):272-84. PMC: 4222661. DOI: 10.1016/j.taap.2014.07.017. View

5.
Wang H, Han R, Yang L, Shi J, Liu Z, Hu Y . Design and Synthesis of Core-Shell-Shell Upconversion Nanoparticles for NIR-Induced Drug Release, Photodynamic Therapy, and Cell Imaging. ACS Appl Mater Interfaces. 2016; 8(7):4416-23. DOI: 10.1021/acsami.5b11197. View